围产期母鼠染毒双酚A对雄性子代脑内谷氨酸N-甲基-D-天冬氨酸受体发育的影响

为了探讨围生期双酚A (bisphenol A,BPA) 暴露对雄性子代大鼠海马和前皮层谷氨酸N- 甲基-D- 天冬氨酸受体(N-methyl-D-aspartate Receptor, NMDAR) 表达的影响,作者通过对妊娠第7 天至仔鼠出生后21 天的母鼠灌胃染毒BPA (200, 50, 5, 0.5 mg/(kg·d)),用Western-blot法分别检测出生后4、7、14、21、56 天的雄性仔鼠海马和前皮层NMDA 受体NR1、NR2A、2B 亚基的表达。结果显示,在海马区,较低剂量(0.5～50 mg/(kg·d))BPA 剂量依赖性地下调NMDA 受体各亚基表达,而高剂量(200 mg/(kg·d)) BPA 最显著下调NR1 表达,却对
NR2A、2B的影响最小;但所有BPA剂量组的NMDA受体亚基表达均显著低于对照组。在前皮层,NMDAR 亚基表达对BPA 的敏感性相对较低,只有较高剂量(50～200 mg/(kg·d)) BPA 可明显下调NR2A、2B 亚基表达。此外,BPA 明显改变NMDAR 的亚基组成,NR2A/NR1 和NR2B/NR1 比值在海马区被200 mg/(kg·d) BPA 上调,在前皮层却被0.5 mg/(kg·d) BPA 上调;其它剂量BPA 均下调两脑区的该比值。以上结果提示,母体围生期双酚A 暴露下调NMDA 受体表达和亚基组成,这可能是BPA 影响雄性子代脑发育的机制之一。     

流体剪切力对成骨细胞LEF-1蛋白表达的影响

目的：探讨MC3T3-E1细胞在流体剪切力作用下LEF-1的表达。方法：通过流体剪切加载系统对MC3T3-E1爬片细胞施加12dyn/cm的流体剪切力,分别作用0h,2h,4h,8h,12h,用RT-PCR方法检测细胞受力前后LEF-1 mRNA表达的变化;应用免疫荧光双标记法检测不同时间点流体剪切力作用下MC3T3-E1细胞中的LEF-1 mRNA表达改变。结果：RT-PCR和免疫荧光双标记法的结果表明12dyn/cm 8h流体剪切力作用下的MC3T3-E1细胞LEF-1 mRNA的表达较其它各组明显增强。结论：通过流体剪切力力学刺激,激活了成骨细胞LEF-1/TCF1转录活动,LEF-1 mRNA的表达增强可能是成骨细胞经典Wnt信号通路对剪切应力的应答反应。     

不同温度下成骨细胞增殖及其OPG/RANKL mRNA表达的影响

目的:探讨不同温度下对小鼠成骨细胞MC3T3-E1的增殖以及OPG/RANKL表达水平的影响。方法:1.以小鼠成骨细胞MC3T3-E1为体外实验模型,MTT法检检测细胞的增殖情况。2.RT-PCR方法检测MC3T3-E1OPG/RANKL mRNA的表达水平。结果:设定对照组为37℃,高于对照组(38℃-39℃-40℃-41℃-42℃)分别作用于MC3T3-E1细胞1小时/天,连续1周,可刺激细胞增殖,OD值显著增加(P<0.05)。同时可增加OPG mRNA表达,降低RANKL mRNA表达,呈温度梯度依赖性。结论:热刺激促进MC3T3-E1细胞增殖,同时通过调节OPG/RANKL mRNA的表达,直接促进骨形成,抑制骨吸收。     

雌激素快速影响大鼠发育期海马NMDA受体活性的机制

为了探讨雌激素对发育期大鼠海马NMDA受体活性的快速影响,对出生后18d的雄性大鼠进行苯甲酸雌二醇皮下注射,1h后用WesternBlot检测海马NMDA受体NR1和NR2B亚基、雌激素β受体、ERK1/2蛋白的表达,以及NR2B和ERK1/2的磷酸化水平;并通过海马内给予雌激素受体拮抗剂ICI182,780和MEK1/2抑制剂U0126预处理,进一步分析苯甲酸雌二醇影响NR2B和ERK1/2磷酸化的作用机制。结果显示,苯甲酸雌二醇不影响NR1、NR2B、ERβ和ERK1/2的表达,但能快速增强NR2B和ERK1/2的磷酸化水平。雌激素受体拮抗剂ICI182,780和MEK1/2抑制剂U0126均能明显抑制苯甲酸雌二醇诱导的NR2B和ERK1/2磷酸化水平的增加。以上结果提示,雌激素可能通过雌激素受体的非基因组机制激活ERK/MAPK信号转导通路,快速诱导NMDA受体NR2B亚基磷酸化,激活NMDA受体。     

高浓度葡萄糖通过p38MAPK-TXNIP/TRX-ROS通路抑制MC3T3-E1细胞成骨分化

目的：研究高浓度葡萄糖抑制MC3T3-E1细胞成骨分化的机理。方法：建立MC3T3-E1细胞成骨分化诱导体系,观察不同浓度葡萄糖（5.5mM和22mM）对MC3T3-E1细胞成骨分化的影响;用不同浓度的p38 MAPK抑制剂Fr167653（0.1μM、1.0μM和10μM）进行药物干预,观察MC3T3-E1细胞在22mM葡萄糖浓度下成骨分化的变化情况。通过钙含量检测、Real time PCR检测相关分化的变化;用Western Blot方法检测MC3T3-E1细胞分化过程中p38 MAPK磷酸化状态、TXNIP表达水平的变化;使用胰岛素二硫键还原法检测细胞内TRX活性水平;使用活性氧检测试剂盒检测细胞内自由氧生成水平。结果：体外诱导条件下,高浓度（22mM）葡萄糖通过升高p38 MAPK磷酸化水平,上调TXNIP表达水平,同时降低TRX活性,使细胞内自由氧生成增加,抑制MC3T3-E1细胞的成骨分化;Fr167653通过抑制p38 MAPK磷酸化,下调TXNIP表达同时升高TRX活性,抑制细胞内自由氧生成,解除高浓度葡萄糖对细胞成骨分化的抑制作用。结论：高浓度葡萄糖通过p38 MAPK-TXNIP/TRX-ROS信号通路抑制MC3T3-E1细胞成骨分化。     

甲状旁腺激素对成骨细胞中ClC-3 氯通道表达及成骨分化影响的研究

目的:观察甲状旁腺激素(PTH)对成骨细胞中Cl C-3氯通道表达及成骨分化影响,初步探索Cl C-3介导PTH在细胞成骨分化中的作用。方法:采用10-8M、10-9M、10-10M PTH持续刺激和间断刺激MC3T3-E1细胞72 h后,通过CCK-8试剂盒法检测MC3T3-E1细胞的增殖情况,Real-Time PCR法检测MC3T3-E1细胞中Clcn3及成骨相关基因Alp、Runx2的表达情况,免疫荧光法检测10-9M PTH不同给药方式下对Cl C-3蛋白表达的影响。结果 :经不同浓度PTH连续和间断处理72 h后,结果显示10-9 M PTH间断刺激的MC3T3-E1细胞的增殖能力最强,且其Alp、Runx2 m RNA表达均高于10-8 M组和10-10 M组(P<0.05),而相同浓度间断刺激的MC3T3-E1细胞成骨相关基因的表达均高于持续刺激组,以10-9M间断刺激组差异最显著(P<0.05),而10-8 M和10-10M均无统计学差异(P>0.05),10-9 M PTH刺激的MC3T3-E1细胞中Cl C-3蛋白表达也显著增加(P<0.05)。结论 :成骨细胞的Cl C-3氯通道能够响应PTH的刺激发生变化,并伴随着成骨相关基因Alp、Runx2表达的增强。     

癫痫大鼠海马NMDA受体亚基NR2A和BDNFmRNA水平的检测

目的通过锂一匹罗卡品癫痫模型（ithium—pilocarpine seizures rats model of epilepsy,LPS）,研究NMDA受体亚基NR2A、BDNF mRNA的表达,探讨NR2A、BDNF在LPS中的作用。方法建立氯化锂-匹罗卡品大鼠模型,运用原位杂交技术检测致痫后各组不同时间点海马CAI、CA3及DG区NR2A与BDNF mRNA的表达。结果LPS海马NR2A、BDNF mRNA在各观察时间点及部位模型组与正常对照组比较均有明显上调,且有显著统计学差异（P〈0．05）。模型组NR2A mRNA的表达上调7d达峰值（P〈0．05）;而BDNF mRNA表达上调14d达峰值。VPA干预组NR2A mRNA在大鼠海马不同时间及部位（除1d的CA3区）的表达较模型组明显下调（P〈0．05）;BDNF mRNA在大鼠海马不同时间及部位（除28d的DG区）的表达较模型组明显下调（P〈0．05）。结论锂－匹罗卡品腹腔注射可诱导大鼠海马NR2A和BDNF mRNA的表达明显上调;NR2A mRNA表达的增强可能是诱导调控BDNF mRNA表达增强的重要机制之一,说明NMDA受体亚基NR2A可能成为抑制癫痫发作的新靶点。     

高浓度葡萄糖通过p38MAPK-TXNIP/TRX-ROS通路抑制MC3T3-E1 细胞成骨分化

目的：研究高浓度葡萄糖抑制MC3T3-E1细胞成骨分化的机理。方法：建立MC3T3-E1 细胞成骨分化诱导体系,观察不同浓 度葡萄糖（5.5mM 和22mM）对MC3T3-E1 细胞成骨分化的影响;用不同浓度的p38 MAPK 抑制剂Fr167653（0.1 滋M、1.0 滋M 和 10 滋M）进行药物干预,观察MC3T3-E1 细胞在22mM葡萄糖浓度下成骨分化的变化情况。通过钙含量检测、Real time PCR 检测 相关分化的变化;用Western Blot 方法检测MC3T3-E1 细胞分化过程中p38 MAPK 磷酸化状态、TXNIP 表达水平的变化;使用胰 岛素二硫键还原法检测细胞内TRX活性水平;使用活性氧检测试剂盒检测细胞内自由氧生成水平。结果：体外诱导条件下,高浓 度（22mM）葡萄糖通过升高p38 MAPK 磷酸化水平,上调TXNIP 表达水平,同时降低TRX 活性,使细胞内自由氧生成增加,抑制 MC3T3-E1 细胞的成骨分化;Fr167653通过抑制p38 MAPK 磷酸化,下调TXNIP 表达同时升高TRX活性,抑制细胞内自由氧生 成,解除高浓度葡萄糖对细胞成骨分化的抑制作用。结论：高浓度葡萄糖通过p38 MAPK-TXNIP/TRX-ROS 信号通路抑制 MC3T3-E1细胞成骨分化。     

小鼠RNA干扰基因RelA慢病毒载体的构建与鉴定

目的：构建小鼠RelA 基因的RNA 干扰慢病毒载体,转染小鼠成骨样细胞并鉴定。方法：针对小鼠RelA 基因序列,设计特异 性的shRNA 序列,应用基因重组技术插入慢病毒载体GV-248。得到的重组质粒转化感受态大肠杆菌DH5-alpha,筛选得到阳性克隆 并扩大培养。所得质粒进行测序分析确定载体构建成功。重组质粒载体及包装辅助质粒转染293T 细胞,得到目的病毒并测定相 应病毒滴度。慢病毒转染MC3T3-E1 细胞后,Real-time PCR 及Western blot 检测MC3T3-E1 细胞RelA 基因及成骨相关基因 ALP、OCN、RANKL的表达。结果：成功构建小鼠RelA 基因的RNA干扰慢病毒载体,感染MC3T3-E1 细胞后,RelA 基因的表达 明显受到抑制,同时RANKL基因表达水平明显下降,ALP、OCN基因表达水平明显上升。结论：成功构建了小鼠RelA 基因的 RNA 干扰慢病毒载体。当小鼠成骨细胞RelA基因表达被干扰,NF-资B 通路被抑制后,小鼠成骨细胞成骨相关基因ALP、OCN的 表达明显上升,成骨功能增强;同时RANKL 的表达明显下降,其介导的破骨细胞骨吸收功能减弱。     

原子力显微镜技术检测几种骨组织细胞力学性能

为了探究几种骨组织细胞系的力学性能及其与细胞功能的关系,该文采用原子力显微镜压陷法分别检测了前成骨细胞系（2T3和MC3T3-E1）、前骨细胞系（MLO-A5）和骨样细胞系（MLO-Y4）的杨氏模量,利用激光共聚焦显微镜观察了这几种细胞微丝和微管的排布。结果显示,2T3、MC3T3-E1、MLO-A5和MLO-Y4细胞的杨氏模量分别为（7000±2015）Pa、（6600±2024）Pa、（4700±644）Pa和（4500±1622）Pa,与原代骨组织细胞的杨氏模量及变化趋势保持一致,但两种前成骨细胞的杨氏模量要显著高于前骨细胞和骨细胞。细胞荧光染色结果表日月＇前成骨细胞细胞核周围的微丝和微管分布密度要高于前骨细胞和骨细胞,而前骨细胞MLO-A5,尤其是骨细胞MLO-Y4的骨架主要集中于细胞突触和边缘,这可能是导致几种细胞力学性能差异的原因。该研究从生物力学的角度为进一步深入理解骨组织细胞结构与功能的关系提供了实验依据。     

Race and Racism in America and in Anthropology

Race in North America: Origin and Evolution of a Worldview . Audrey Smedley
Anthropology and Race . Eugenia Shanklin     

Trajectories and Constraints in Brain Evolution in Primates and Cetaceans

A negative allometric relationship between body mass (BM) and brain size (BS) can be observed for many vertebrate groups. In the past decades, researchers have proposed several hypotheses to explain this finding, but none is definitive and some are possibly not mutually exclusive. Certain species diverge markedly (positively or negatively) from the mean of the ratio BM/BS expected for a particular taxonomic group. It is possible to define encephalization quotient (EQ) as the ratio between the actual BS and the expected brain size. Several cetacean species show higher EQs compared to all primates, except modern humans. The process that led to big brains in primates and cetaceans produced different trajectories, as shown by the organizational differences observed in every encephalic district (e.g., the cortex). However, these two groups both convergently developed complex cognitive abilities. The comparative study on the trajectories through which the encephalization process has independently evolved in primates and cetaceans allows a critical appraisal of the causes, the time and the mode of quantitative and qualitative development of the brain in our species and in the hominid evolutionary lineage.     

Degradation and conversion of somatostatin in normal and diabetic rats in vivo and in vitro

Plasma somatostatin-like immunoreactivity in the portal and jugular veins of streptozotocin diabetic rats was compared with that in normal control rats. In the diabetic group, somatostatin levels in the portal (p less than 0.05) and jugular (p less than 0.01) veins were both elevated compared with those in the control group. Moreover, the degree of elevation was greater in the jugular vein than in the portal vein. To further investigate the role of the liver in the clearance of somatostatin-28 in vivo, 2 micrograms of somatostatin-28 was administered as a bolus into the external jugular vein of intact and functionally hepatectomized rats. The mean half-time of somatostatin-28 was significantly longer in intact diabetic rats than in controls (p less than 0.05). The functional hepatectomy did not cause a significant difference in the half-time in diabetic rats but made it longer in control rats. These results suggest that the longer half-time of somatostatin-28 in diabetic rats in vivo is due to its slower hepatic clearance. The hepatic clearance of somatostatin-28 and somatostatin-14 was further studied in vitro using a recirculating liver perfusion method. The hepatic clearance of 1.2 nM of either somatostatin-28 or somatostatin-14 was significantly lower in diabetic rats than in controls (p less than 0.01). This indicates that elevated plasma somatostatin levels in diabetic rats are caused at least in part by decreased hepatic clearance of somatostatin.(ABSTRACT TRUNCATED AT 250 WORDS)     

Electroejaculation in chimpanzees and gorillas and artificial insemination in chimpanzees

Electroejaculation was performed in 3 chimpanzees, 1 pygmy chimpanzee, and 2 gorillas with an instrument that delivers a modified sine wave current with a frequency of 24 Hz. The current stimuli were applied by a rectal probe with longitudinal electrodes. The electrical parameters varied from 6 to 12 V and from 30 to 40 mA for response of erection and lay between 8 and 18 V and between 40 and 145 mA during semen emission. Eleven chimpanzee semen samples showed the following data (x ± SD): total volume 1.9 ± 1.3 ml, volume of the liquid fraction 0.3 ± 0.2 ml, spermatozoa per ejaculate 743 ± 376 × 10⁶, sperm motility 52.7 ± 9.6%, morphologically abnormal spermatozoa 12.2 ± 7.5%. From an adult gorilla, three semen samples were collected, in each case without spermatozoa. The electrostimulation of a 6-year-old gorilla led to an erection, but not to semen emission. Three female chimpanzees were inseminated with fresh or frozen semen, each of them within three different estrous cycles. None of these inseminations led to a pregnancy.     

Deoxynivalenol and nivalenol in wheat and by-products in Argentina

The deoxynivalenol and nivalenol contamination in wheat and by-products obtained through milling was analized by Trucksess method slightly modified in the proportion of acetonitrile—water (3:1). Only one sample of wheat showed deoxynivalenol contamination, 1,200μg/kg. No samples obtained in different stages of the milling were contaminated with deoxynivalenol or nivalenol. In the commercial wheat flours the levels found ranged between 400 and 800μg/kg, as follows: 400μ/kg, 5 samples; 800jug/kg, 1 sample.     

Obestatin and ghrelin in obese and in pregnant women

We identified, through qPCR, receptor mRNA for a number of gut peptides in female human omental fat: the incretins, GIP and GLP-1, the orexigenic peptides PYY-Y1 and -Y2 and ghrelin, and the anorexigenic peptide obestatin. Four cohorts of women were examined: lean controls (BMI<23), obese (BMI>41), obese diabetic and term pregnant women. Human fat expressed receptor mRNAs for all six peptides. Pregnant women expressed roughly three times as much orphan GPR-39 receptor, a proposed obestatin receptor, than other women and less than half as much of the ghrelin receptor (GHSR-1a). An immunoblot probed with a GPR-39 selective antibody yielded a single band corresponding to the correct molecular weight (52 kDa) for the proposed obestatin receptor. Fluorescent immunohistochemistry of human fat employing the same antibody indicated the receptor protein was localized to the adipocyte cell membrane. The concentration of obestatin circulating in blood was measured in the same cohort of women and was significantly lower in obese and obese diabetic women compared to control.     

Variation in infectivity and aggressiveness in space and time in wild host-pathogen systems: causes and consequences

Variation in host resistance and in the ability of pathogens to infect and grow (i.e. pathogenicity) is important as it provides the raw material for antagonistic (co)evolution and therefore underlies risks of disease spread, disease evolution and host shifts. Moreover, the distribution of this variation in space and time may inform us about the mode of coevolutionary selection (arms race vs. fluctuating selection dynamics) and the relative roles of G × G interactions, gene flow, selection and genetic drift in shaping coevolutionary processes. Although variation in host resistance has recently been reviewed, little is known about overall patterns in the frequency and scale of variation in pathogenicity, particularly in natural systems. Using 48 studies from 30 distinct host–pathogen systems, this review demonstrates that variation in pathogenicity is ubiquitous across multiple spatial and temporal scales. Quantitative analysis of a subset of extensively studied plant–pathogen systems shows that the magnitude of within‐population variation in pathogenicity is large relative to among‐population variation and that the distribution of pathogenicity partly mirrors the distribution of host resistance. At least part of the variation in pathogenicity found at a given spatial scale is adaptive, as evidenced by studies that have examined local adaptation at scales ranging from single hosts through metapopulations to entire continents and – to a lesser extent – by comparisons of pathogenicity with neutral genetic variation. Together, these results support coevolutionary selection through fluctuating selection dynamics. We end by outlining several promising directions for future research.